腰椎穿刺可用于在中枢神经系统药物的临床试验期间测量药物和/或药效学生物标志物的浓度。我们在一项首次人体研究中报告了一例腰椎穿刺后头痛(PLPH),报告为严重不良事件.一名20岁男子接受200mg的研究产品(IP)7天,并在IP给药之前(第1天,给药前)和7天和多次IP给药之后(第7天,给药后1小时)进行腰椎穿刺进行脑脊液取样。在第8天出院后,受试者抱怨头痛,恶心,呕吐,颈部僵硬度,四肢麻木。症状发生在他起床时,在他保持仰卧位几分钟后消失。五天后,他参观了主要医院的神经科诊所。神经科医生建议住院治疗以进行进一步评估和症状管理,受试者随后被送进医院。生命体征没有异常发现,实验室结果,或者脑部计算机断层扫描.他的症状在住院期间消失了。区分头痛是IP相关还是腰椎穿刺相关是很重要的。因此,了解PLPH的临床特征和鉴别诊断是最重要的。此外,如果发生严重的PLPH,对于PLPH的鉴别诊断,应考虑神经科医师的咨询和影像学检查.
A lumbar puncture can be used to measure the concentrations of drugs and/or pharmacodynamic biomarkers during clinical trials of central nervous system drugs. We report a
case of a post lumbar puncture headache (PLPH) in a first-in-human study, which was reported as a serious adverse event. A 20-year-old man received 200 mg of the investigational product (IP) for 7 days and underwent a lumbar puncture for cerebrospinal fluid sampling before IP administration (Day 1, pre-dose) and after 7 days and multiple IP administrations (Day 7, 1 hour post-dose). After discharge on Day 8, the subject complained of headache, nausea, vomiting, neck stiffness, and numbness of the extremities. The symptoms occurred when he got up and disappeared after he remained in the supine position for several minutes. Five days later, he visited the neurology clinic of the main hospital. The neurologist recommended hospitalization for further evaluation and symptom management, and the subject was then admitted to the hospital. There were no abnormal findings in vital signs, laboratory results, or brain-computed tomography. His symptoms disappeared during the hospitalization period. It was important to distinguish whether the headache was IP-related or lumbar puncture-related. Therefore, knowledge of clinical characteristics and differential diagnosis of PLPH is paramount. Furthermore, if severe PLPH occurs, a consultation with a neurologist and imaging studies should be considered for a differential diagnosis of PLPH.